{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T11:09:23Z","timestamp":1778238563636,"version":"3.51.4"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,9]],"date-time":"2024-10-09T00:00:00Z","timestamp":1728432000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,10,9]],"date-time":"2024-10-09T00:00:00Z","timestamp":1728432000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["HL166257"],"award-info":[{"award-number":["HL166257"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["HL166257"],"award-info":[{"award-number":["HL166257"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["HL166257"],"award-info":[{"award-number":["HL166257"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["AI148239-01A1"],"award-info":[{"award-number":["AI148239-01A1"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["AI148239-01A1"],"award-info":[{"award-number":["AI148239-01A1"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-71180-1","type":"journal-article","created":{"date-parts":[[2024,10,9]],"date-time":"2024-10-09T10:02:31Z","timestamp":1728468151000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Differential requirement of formyl peptide receptor 1 in macrophages and neutrophils in the host defense against Mycobacterium tuberculosis Infection"],"prefix":"10.1038","volume":"14","author":[{"given":"Tanvir Noor","family":"Nafiz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Poornima","family":"Sankar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lokesh K.","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert P.","family":"Rousseau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohd","family":"Saqib","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Selvakumar","family":"Subbian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suraj P.","family":"Parihar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bibhuti B.","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,10,9]]},"reference":[{"key":"71180_CR1","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1056\/NEJMp2118145","volume":"386","author":"M Pai","year":"2022","unstructured":"Pai, M., Kasaeva, T. & Swaminathan, S. Covid-19\u2019s devastating effect on tuberculosis care\u2014A path to recovery. N. Engl. J. Med. 386, 1490\u20131493 (2022).","journal-title":"N. Engl. J. Med."},{"key":"71180_CR2","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a018499","volume":"5","author":"AJ Pag\u00e1n","year":"2014","unstructured":"Pag\u00e1n, A. J. & Ramakrishnan, L. Immunity and immunopathology in the tuberculous granuloma. Cold Spring Harb. Perspect. Med. 5, a018499 (2014).","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"71180_CR3","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/s41572-020-0161-5","volume":"6","author":"M Pai","year":"2020","unstructured":"Pai, M. Tuberculosis: The story after the Primer. Nat. Rev. Dis. Primers 6, 29\u201332 (2020).","journal-title":"Nat. Rev. Dis. Primers"},{"key":"71180_CR4","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.624597","volume":"11","author":"V Kumar","year":"2020","unstructured":"Kumar, V. The trinity of cGAS, TLR9, and ALRs guardians of the cellular galaxy against host-derived self-DNA. Front. Immunol. 11, 624597 (2020).","journal-title":"Front. Immunol."},{"key":"71180_CR5","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/nature13684","volume":"512","author":"P Moura-Alves","year":"2014","unstructured":"Moura-Alves, P. et al. AhR sensing of bacterial pigments regulates antibacterial defence. Nature 512, 387\u2013392 (2014).","journal-title":"Nature"},{"key":"71180_CR6","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1000474","volume":"5","author":"DME Bowdish","year":"2009","unstructured":"Bowdish, D. M. E. et al. MARCO, TLR2, and CD14 are required for macrophage cytokine responses to mycobacterial trehalose dimycolate and Mycobacterium tuberculosis. PLoS Pathog 5, e1000474 (2009).","journal-title":"PLoS Pathog"},{"key":"71180_CR7","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1189\/jlb.2RI0815-354RR","volume":"99","author":"L Li","year":"2016","unstructured":"Li, L. et al. New development in studies of formyl-peptide receptors: critical roles in host defense. J. Leukoc Biol. 99, 425\u2013435 (2016).","journal-title":"J. Leukoc Biol."},{"key":"71180_CR8","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.cytogfr.2006.09.009","volume":"17","author":"I Migeotte","year":"2006","unstructured":"Migeotte, I., Communi, D. & Parmentier, M. Formyl peptide receptors: a promiscuous subfamily of G protein-coupled receptors controlling immune responses. Cytokine Growth Factor Rev. 17, 501\u2013519 (2006).","journal-title":"Cytokine Growth Factor Rev."},{"key":"71180_CR9","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/s41586-019-1570-z","volume":"574","author":"P Osei-Owusu","year":"2019","unstructured":"Osei-Owusu, P., Charlton, T. M., Kim, H. K., Missiakas, D. & Schneewind, O. FPR1 is the plague receptor on host immune cells. Nature 574, 57\u201362 (2019).","journal-title":"Nature"},{"key":"71180_CR10","doi-asserted-by":"publisher","first-page":"2464","DOI":"10.4049\/jimmunol.1900430","volume":"204","author":"M Zhang","year":"2020","unstructured":"Zhang, M. et al. A Critical role of formyl peptide receptors in host defense against Escherichia coli. J. Immunol. 204, 2464\u20132473 (2020).","journal-title":"J. Immunol."},{"key":"71180_CR11","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.4049\/jimmunol.181.2.1429","volume":"181","author":"EL Southgate","year":"2008","unstructured":"Southgate, E. L. et al. Identification of formyl peptides from Listeria monocytogenes and Staphylococcus aureus as potent chemoattractants for mouse neutrophils. J. Immunol. 181, 1429\u20131437 (2008).","journal-title":"J. Immunol."},{"key":"71180_CR12","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1111\/imm.12324","volume":"143","author":"S Oldekamp","year":"2014","unstructured":"Oldekamp, S. et al. Lack of formyl peptide receptor 1 and 2 leads to more severe inflammation and higher mortality in mice with of pneumococcal meningitis. Immunology 143, 447\u2013461 (2014).","journal-title":"Immunology"},{"key":"71180_CR13","first-page":"668","volume":"221","author":"E Wei\u00df","year":"2020","unstructured":"Wei\u00df, E., Schlatterer, K., Beck, C., Peschel, A. & Kretschmer, D. Formyl-peptide receptor activation enhances phagocytosis of community-acquired methicillin-resistant Staphylococcus aureus. J. Infect Dis. 221, 668\u2013678 (2020).","journal-title":"J. Infect Dis."},{"key":"71180_CR14","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1016\/j.ajpath.2015.01.020","volume":"185","author":"DA Dorward","year":"2015","unstructured":"Dorward, D. A. et al. The role of formylated peptides and formyl peptide receptor 1 in governing neutrophil function during acute inflammation. Am. J. Pathol. 185, 1172\u20131184 (2015).","journal-title":"Am. J. Pathol."},{"key":"71180_CR15","doi-asserted-by":"publisher","first-page":"e125937","DOI":"10.1172\/jci.insight.125937","volume":"5","author":"J Leslie","year":"2020","unstructured":"Leslie, J. et al. FPR-1 is an important regulator of neutrophil recruitment and a tissue-specific driver of pulmonary fibrosis. JCI Insight 5, e125937 (2020).","journal-title":"JCI Insight"},{"key":"71180_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.593247","volume":"11","author":"J Qi","year":"2020","unstructured":"Qi, J. et al. Identification of FPR3 as a unique biomarker for targeted therapy in the immune microenvironment of breast cancer. Front Pharmacol. 11, 593247 (2020).","journal-title":"Front Pharmacol."},{"key":"71180_CR17","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s00251-008-0277-3","volume":"60","author":"JM Gripentrog","year":"2008","unstructured":"Gripentrog, J. M., Mills, J. S., Saari, G. J. & Miettinen, H. M. Variable responses of formyl peptide receptor haplotypes toward bacterial peptides. Immunogenetics 60, 83\u201393 (2008).","journal-title":"Immunogenetics"},{"key":"71180_CR18","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1046\/j.1365-2249.2003.02212.x","volume":"133","author":"M Beigier-Bompadre","year":"2003","unstructured":"Beigier-Bompadre, M. et al. Monocytes and neutrophils from tuberculosis patients are insensitive to anti-inflammatory effects triggered by the prototypic formyl peptide N-formyl-methionyl-leucyl-phenylalanine (FMLP). Clin. Exp. Immunol. 133, 267\u2013274 (2003).","journal-title":"Clin. Exp. Immunol."},{"key":"71180_CR19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1000362","volume":"5","author":"HL Rittner","year":"2009","unstructured":"Rittner, H. L. et al. Mycobacteria attenuate nociceptive responses by formyl peptide receptor triggered opioid peptide release from neutrophils. PLoS Pathog 5, e1000362 (2009).","journal-title":"PLoS Pathog"},{"key":"71180_CR20","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.ijid.2020.09.1056","volume":"101","author":"Y-C Chen","year":"2020","unstructured":"Chen, Y.-C. et al. Blood M2a monocyte polarization and increased formyl peptide receptor 1 expression are associated with progression from latent tuberculosis infection to active pulmonary tuberculosis disease. Int. J. Infect. Dis. 101, 210\u2013219 (2020).","journal-title":"Int. J. Infect. Dis."},{"key":"71180_CR21","doi-asserted-by":"publisher","first-page":"2264","DOI":"10.1021\/acsinfecdis.0c00826","volume":"7","author":"JT Mattila","year":"2021","unstructured":"Mattila, J. T. et al. Retention of 64Cu-FLFLF, a formyl peptide receptor 1-specific PET probe, correlates with macrophage and neutrophil abundance in lung granulomas from cynomolgus macaques. ACS Infect Dis. 7, 2264\u20132276 (2021).","journal-title":"ACS Infect Dis."},{"key":"71180_CR22","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.tube.2018.01.001","volume":"108","author":"LW Locke","year":"2018","unstructured":"Locke, L. W. et al. Use of a leukocyte-targeted peptide probe as a potential tracer for imaging the tuberculosis granuloma. Tuberculosis (Edinb) 108, 201\u2013210 (2018).","journal-title":"Tuberculosis (Edinb)"},{"key":"71180_CR23","doi-asserted-by":"publisher","first-page":"1790","DOI":"10.1172\/JCI200421027","volume":"114","author":"CM Fremond","year":"2004","unstructured":"Fremond, C. M. et al. Fatal Mycobacterium tuberculosis infection despite adaptive immune response in the absence of MyD88. J. Clin. Invest. 114, 1790\u20131799 (2004).","journal-title":"J. Clin. Invest."},{"key":"71180_CR24","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/j.immuni.2011.12.002","volume":"35","author":"KD Mayer-Barber","year":"2011","unstructured":"Mayer-Barber, K. D. et al. Innate and adaptive interferons suppress IL-1\u03b1 and IL-1\u03b2 production by distinct pulmonary myeloid subsets during Mycobacterium tuberculosis infection. Immunity 35, 1023\u20131034 (2011).","journal-title":"Immunity"},{"key":"71180_CR25","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/nature13489","volume":"511","author":"KD Mayer-Barber","year":"2014","unstructured":"Mayer-Barber, K. D. et al. Host-directed therapy of tuberculosis based on interleukin-1 and type I interferon crosstalk. Nature 511, 99\u2013103 (2014).","journal-title":"Nature"},{"key":"71180_CR26","doi-asserted-by":"publisher","first-page":"e0313421","DOI":"10.1128\/mBio.03134-21","volume":"12","author":"D Silv\u00e9rio","year":"2021","unstructured":"Silv\u00e9rio, D., Gon\u00e7alves, R., Appelberg, R. & Saraiva, M. Advances on the role and applications of interleukin-1 in tuberculosis. mBio 12, e0313421 (2021).","journal-title":"mBio"},{"key":"71180_CR27","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.4049\/jimmunol.179.2.1178","volume":"179","author":"CM Fremond","year":"2007","unstructured":"Fremond, C. M. et al. IL-1 receptor-mediated signal is an essential component of MyD88-dependent innate response to Mycobacterium tuberculosis infection. J. Immunol. 179, 1178\u20131189 (2007).","journal-title":"J. Immunol."},{"key":"71180_CR28","doi-asserted-by":"publisher","first-page":"891","DOI":"10.3389\/fimmu.2020.00891","volume":"11","author":"CG Winchell","year":"2020","unstructured":"Winchell, C. G. et al. Evaluation of IL-1 blockade as an adjunct to linezolid therapy for tuberculosis in mice and macaques. Front Immunol. 11, 891 (2020).","journal-title":"Front Immunol."},{"key":"71180_CR29","doi-asserted-by":"publisher","first-page":"522","DOI":"10.4049\/jimmunol.179.1.522","volume":"179","author":"D Ordway","year":"2007","unstructured":"Ordway, D. et al. The hypervirulent Mycobacterium tuberculosis strain HN878 induces a potent TH1 response followed by rapid down-regulation. J. Immunol. 179, 522\u2013531 (2007).","journal-title":"J. Immunol."},{"key":"71180_CR30","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1093\/infdis\/jiz663","volume":"221","author":"JA Chore\u00f1o-Parra","year":"2020","unstructured":"Chore\u00f1o-Parra, J. A. et al. Mycobacterium tuberculosis HN878 infection induces human-like B-Cell follicles in mice. J. Infect. Dis. 221, 1636\u20131646 (2020).","journal-title":"J. Infect. Dis."},{"key":"71180_CR31","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1038\/nature09247","volume":"466","author":"MPR Berry","year":"2010","unstructured":"Berry, M. P. R. et al. An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis. Nature 466, 973\u2013977 (2010).","journal-title":"Nature"},{"key":"71180_CR32","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1084\/jem.20172020","volume":"215","author":"L Huang","year":"2018","unstructured":"Huang, L., Nazarova, E. V., Tan, S., Liu, Y. & Russell, D. G. Growth of Mycobacterium tuberculosis in vivo segregates with host macrophage metabolism and ontogeny. J. Exp. Med. 215, 1135\u20131152 (2018).","journal-title":"J. Exp. Med."},{"key":"71180_CR33","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1038\/ni.1758","volume":"10","author":"M Divangahi","year":"2009","unstructured":"Divangahi, M. et al. Mycobacterium tuberculosis evades macrophage defenses by inhibiting plasma membrane repair. Nat. Immunol. 10, 899\u2013906 (2009).","journal-title":"Nat. Immunol."},{"key":"71180_CR34","doi-asserted-by":"crossref","unstructured":"Dallenga, T. et al. M.\u00a0tuberculosis-induced necrosis of infected neutrophils promotes bacterial growth following phagocytosis by macrophages. Cell Host Microbe 22, 519\u2013530.e3 (2017).","DOI":"10.1016\/j.chom.2017.09.003"},{"key":"71180_CR35","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1007\/s10753-007-9040-4","volume":"30","author":"A-L Stenfeldt","year":"2007","unstructured":"Stenfeldt, A.-L. et al. Cyclosporin H, Boc-MLF and Boc-FLFLF are antagonists that preferentially inhibit activity triggered through the formyl peptide receptor. Inflammation 30, 224\u2013229 (2007).","journal-title":"Inflammation"},{"key":"71180_CR36","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.freeradbiomed.2017.02.038","volume":"106","author":"S-C Yang","year":"2017","unstructured":"Yang, S.-C. et al. Dipeptide HCH6-1 inhibits neutrophil activation and protects against acute lung injury by blocking FPR1. Free Radic. Biol. Med. 106, 254\u2013269 (2017).","journal-title":"Free Radic. Biol. Med."},{"key":"71180_CR37","doi-asserted-by":"publisher","first-page":"5566","DOI":"10.1038\/s41467-020-19412-6","volume":"11","author":"L Moreira-Teixeira","year":"2020","unstructured":"Moreira-Teixeira, L. et al. Type I IFN exacerbates disease in tuberculosis-susceptible mice by inducing neutrophil-mediated lung inflammation and NETosis. Nat. Commun. 11, 5566\u20135618 (2020).","journal-title":"Nat. Commun."},{"key":"71180_CR38","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1038\/s41385-020-0300-z","volume":"14","author":"RR Lovewell","year":"2021","unstructured":"Lovewell, R. R., Baer, C. E., Mishra, B. B., Smith, C. M. & Sassetti, C. M. Granulocytes act as a niche for Mycobacterium tuberculosis growth. Mucosal. Immunol. 14, 229\u2013241 (2021).","journal-title":"Mucosal. Immunol."},{"key":"71180_CR39","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1242\/dmm.019570","volume":"8","author":"SM Irwin","year":"2015","unstructured":"Irwin, S. M. et al. Presence of multiple lesion types with vastly different microenvironments in C3HeB\/FeJ mice following aerosol infection with Mycobacterium tuberculosis. Dis. Model Mech. 8, 591\u2013602 (2015).","journal-title":"Dis. Model Mech."},{"key":"71180_CR40","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1010459","volume":"18","author":"RC Lavin","year":"2022","unstructured":"Lavin, R. C. & Tan, S. Spatial relationships of intra-lesion heterogeneity in Mycobacterium tuberculosis microenvironment, replication status, and drug efficacy. PLoS Pathog 18, e1010459 (2022).","journal-title":"PLoS Pathog"},{"key":"71180_CR41","doi-asserted-by":"crossref","unstructured":"Vaziri, F. & Brosch, R. ESX\/type VII secretion systems-an important way out for mycobacterial proteins. Microbiol Spectr 7 (2019).","DOI":"10.1128\/microbiolspec.PSIB-0029-2019"},{"key":"71180_CR42","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.it.2007.06.002","volume":"28","author":"N Borregaard","year":"2007","unstructured":"Borregaard, N., Sorensen, O. E. & Theilgaard-M\u00f6nch, K. Neutrophil granules: a library of innate immunity proteins. Trends Immunol. 28, 340\u2013345 (2007).","journal-title":"Trends Immunol."},{"key":"71180_CR43","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1002\/JLB.4MIR0220-574RR","volume":"108","author":"C Rosales","year":"2020","unstructured":"Rosales, C. Neutrophils at the crossroads of innate and adaptive immunity. J. Leukoc Biol. 108, 377\u2013396 (2020).","journal-title":"J. Leukoc Biol."},{"key":"71180_CR44","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.tim.2022.10.002","volume":"31","author":"V Poli","year":"2023","unstructured":"Poli, V. & Zanoni, I. Neutrophil intrinsic and extrinsic regulation of NETosis in health and disease. Trends Microbiol. 31, 280\u2013293 (2023).","journal-title":"Trends Microbiol."},{"key":"71180_CR45","doi-asserted-by":"publisher","first-page":"373","DOI":"10.3389\/fcimb.2017.00373","volume":"7","author":"GT Nguyen","year":"2017","unstructured":"Nguyen, G. T., Green, E. R. & Mecsas, J. Neutrophils to the ROScue: Mechanisms of NADPH oxidase activation and bacterial resistance. Front Cell Infect Microbiol. 7, 373 (2017).","journal-title":"Front Cell Infect Microbiol."},{"key":"71180_CR46","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1126\/science.aaa8064","volume":"349","author":"A Warnatsch","year":"2015","unstructured":"Warnatsch, A., Ioannou, M., Wang, Q. & Papayannopoulos, V. Inflammation. Neutrophil extracellular traps license macrophages for cytokine production in atherosclerosis. Science 349, 316\u2013320 (2015).","journal-title":"Science"},{"key":"71180_CR47","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0022043","volume":"6","author":"S Hemmers","year":"2011","unstructured":"Hemmers, S., Teijaro, J. R., Arandjelovic, S. & Mowen, K. A. PAD4-mediated neutrophil extracellular trap formation is not required for immunity against influenza infection. PLoS ONE 6, e22043 (2011).","journal-title":"PLoS ONE"},{"key":"71180_CR48","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1084\/jem.20100239","volume":"207","author":"P Li","year":"2010","unstructured":"Li, P. et al. PAD4 is essential for antibacterial innate immunity mediated by neutrophil extracellular traps. J. Exp. Med. 207, 1853\u20131862 (2010).","journal-title":"J. Exp. Med."},{"key":"71180_CR49","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.smim.2014.09.008","volume":"26","author":"J Bustamante","year":"2014","unstructured":"Bustamante, J., Boisson-Dupuis, S., Abel, L. & Casanova, J.-L. Mendelian susceptibility to mycobacterial disease: genetic, immunological, and clinical features of inborn errors of IFN-\u03b3 immunity. Semin. Immunol. 26, 454\u2013470 (2014).","journal-title":"Semin. Immunol."},{"key":"71180_CR50","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.4049\/jimmunol.1800202","volume":"201","author":"AJ Olive","year":"2018","unstructured":"Olive, A. J., Smith, C. M., Kiritsy, M. C. & Sassetti, C. M. The phagocyte oxidase controls tolerance to Mycobacterium tuberculosis infection. J. Immunol. 201, 1705\u20131716 (2018).","journal-title":"J. Immunol."},{"key":"71180_CR51","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1002\/cyto.a.23767","volume":"95","author":"PM Lelliott","year":"2019","unstructured":"Lelliott, P. M. et al. Rapid quantification of NETs in vitro and in whole blood samples by imaging flow cytometry. Cytometry A 95, 565\u2013578 (2019).","journal-title":"Cytometry A"},{"key":"71180_CR52","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1038\/ni.2474","volume":"14","author":"BB Mishra","year":"2013","unstructured":"Mishra, B. B. et al. Nitric oxide controls the immunopathology of tuberculosis by inhibiting NLRP3 inflammasome-dependent processing of IL-1\u03b2. Nat. Immunol. 14, 52\u201360 (2013).","journal-title":"Nat. Immunol."},{"key":"71180_CR53","doi-asserted-by":"publisher","first-page":"17072","DOI":"10.1038\/nmicrobiol.2017.72","volume":"2","author":"BB Mishra","year":"2017","unstructured":"Mishra, B. B. et al. Nitric oxide prevents a pathogen-permissive granulocytic inflammation during tuberculosis. Nat. Microbiol. 2, 17072\u201317111 (2017).","journal-title":"Nat. Microbiol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-71180-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-71180-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-71180-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,9]],"date-time":"2024-10-09T10:07:51Z","timestamp":1728468471000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-71180-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,9]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["71180"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-71180-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4421561\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,9]]},"assertion":[{"value":"14 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"23595"}}